OpenLB
Open Library of Bioscience
Advanced Search
Nature reviews. Drug discovery
Nov, 2013;12 (11): 811-2.

Bringing together the academic drug discovery community.

Barbara S Slusher, P Jeffrey Conn, Stephen Frye, Marcie Glicksman, Michelle Arkin
Author Information
  1. Barbara S Slusher: 1] ADDC President. She is also the Director of the Brain Science Institute Neuro Translational Drug Discovery Program, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA. [2].
PMID: 24172316 DOI: 10.1038/nrd4155

Abstract

The newly formed Academic Drug Discovery Consortium (ADDC) aims to support the growing numbers of university centres engaged in drug discovery that have emerged in response to recent changes in the drug discovery ecosystem.

References

  1. Nat Rev Drug Discov. 2010 Mar;9(3):203-14 [PMID: 20168317]
  2. Nat Rev Drug Discov. 2011 Feb;10(2):87 [PMID: 21283095]
  3. Nat Rev Drug Discov. 2011 May;10(5):328-9 [PMID: 21532551]
  4. Nature. 2012 Mar 28;483(7391):531-3 [PMID: 22460880]

Grants

  1. R01 MH062646/NIMH NIH HHS
  2. P30 MH075673/NIMH NIH HHS
  3. R01 MH073676/NIMH NIH HHS
  4. U19 MH097056/NIMH NIH HHS
  5. R37 NS031373/NINDS NIH HHS

MeSH Term

Drug Discovery
Drug Industry
Humans
Universities
Journal Article
Article has an altmetric score of 2

Word Cloud

Created with Highcharts 10.0.0drugdiscoverynewlyformedAcademicDrugDiscoveryConsortiumADDCaimssupportgrowingnumbersuniversitycentresengagedemergedresponserecentchangesecosystemBringingtogetheracademiccommunity

Similar Articles

Cited By (17)